Greg Chittick

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

Francisco M. Marty, Drew J. Winston, Roy F. Chemaly et al. · Biology of Blood and Marrow Transplantation · 2018 · 210 citations · Full text

Short-term clinical safety profile of brincidofovir: A favorable benefit–risk proposition in the treatment of smallpox

Greg Chittick, Marion E. Morrison, Thomas M. Brundage et al. · Antiviral Research · 2017 · 126 citations

Antiviral Therapy, Virology, Favorable Benefit–risk Proposition +4

Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial

Isao Ohsawa, Daisuke Honda, Yusuke Suzuki et al. · Allergy · 2020 · 45 citations · Full text

Treatment of Adenovirus (AdV) Infection in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients (pts) with Brincidofovir: Final 36 Week Results from the Advise Trial

Vinod K. Prasad, Genovefa A. Papanicolaou, Gabriela Marón et al. · Biology of Blood and Marrow Transplantation · 2017 · 15 citations · Full text

Adv Disease, Immunology, Transplantation Medicine +16

Long-term Safety and Efficacy Results of Once-Daily Emtricitabine-Based Highly Active Antiretroviral Therapy Regimens in Human Immunodeficiency Virus-Infected Pediatric Subjects

Xavier Sáez‐Llorens, Avy Violari, Dalubuhle Ndiweni et al. · PEDIATRICS · 2008 · 14 citations